Effect of silymarin in prevention of adverse effects of anti tuberculosis drugs.

Completed

• Conditions: Tuberculosis; Drug induced hepatitis; Infection - Other infectious diseases; Oral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colon

• Registration Number: ACTRN12610000621011
• Lead Sponsor: ational Institute of Tuberculosis and Lung Disease (NRITLD)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-07-29
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

New cases of tuberculosis

Exclusion Criteria

1. Infection with Human Immune deficiency virus
2. Infection with hepatitis B virus
3. Infection with hepatitis c virus
4. Abnormal liver function tests in the base
5. Patients treated with the regimens other than Isoniazide, Rifampin, Pyrazinamide.

Study & Design

• Study Type: Interventional
• Study Design: Not specified